domingo, 23 de febrero de 2014
Draft guideline on key aspects for the use of pharmacogenomic methodologies in the pharmacovigilance evaluation of medicinal products
www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500160232&murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario